Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,172
Closed -$391K 221
2026
Q1
$391K Sell
5,172
-30
-0.6% -$2.26K 0.13% 147
2025
Q4
$387K Sell
5,202
-98
-2% -$7.16K 0.15% 146
2025
Q3
$358K Sell
5,300
-193
-4% -$12.8K 0.15% 158
2025
Q2
$358K Buy
5,493
+27
+0.5% +$1.62K 0.17% 140
2025
Q1
$338K Buy
5,466
+56
+1% +$3.71K 0.17% 137
2024
Q4
$390K Sell
5,410
-172
-3% -$13.4K 0.19% 128
2024
Q3
$445K Sell
5,582
-129
-2% -$10.3K 0.22% 116
2024
Q2
$424K Sell
5,711
-131
-2% -$9.82K 0.31% 92
2024
Q1
$455K Sell
5,842
-69
-1% -$5.13K 0.33% 86
2023
Q4
$422K Sell
5,911
-463
-7% -$32.2K 0.33% 86
2023
Q3
$442K Sell
6,374
-99
-2% -$7.48K 0.4% 78
2023
Q2
$524K Buy
6,473
+68
+1% +$5.56K 0.46% 65
2023
Q1
$517K Sell
6,405
-383
-6% -$30.8K 0.47% 60
2022
Q4
$508K Sell
6,788
-98
-1% -$6.98K 0.43% 71
2022
Q3
$444K Buy
6,886
+110
+2% +$7.62K 0.44% 72
2022
Q2
$470K Sell
6,776
-35
-0.5% -$2.6K 0.47% 65
2022
Q1
$523K Buy
6,811
+187
+3% +$13.4K 0.86% 49
2021
Q4
$507K Buy
+6,624
New +$487K 0.45% 71

Other funds holding HOLX

Riverwater Partners's HOLX Position: Q2 2026 in Review

Riverwater Partners sold out of Hologic (HOLX) in Q2 2026, closing a stake of 5,172 shares — an estimated $391K sold.

Riverwater Partners first reported a position in HOLX in Q4 2021 and held it in 18 quarters. The position peaked at $524K in Q2 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Riverwater Partners reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Riverwater Partners sold 5,172 Hologic shares in Q2 2026, an estimated $391K.
  • Riverwater Partners first reported a position in Hologic in Q4 2021 and held it in 18 quarters.
  • Riverwater Partners's Hologic position peaked at $524K in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Riverwater Partners's 13F filing for Q2 2026, filed 14 Aug 2026.